Manju Mary John

Manju John practices at Hartford Healthcare Medical Group Specialists in Middletown, Connecticut.

Manju John's NPI, 1194987313, was assigned on June 29, 2008. Manju John holds Connecticut license 052856.

Manju John's primary practice is Hartford Healthcare Medical Group Specialists, at 420 Saybrook Rd, Middletown, CT 06457 in Lower Ct River Vly County. The practice phone is (860) 246-2071.

Manju John's primary practice is Hartford Healthcare Medical Group Specialists in Middletown, Connecticut. Manju John is also affiliated with Middlesex Hospital. The medical group on file is Hartford HealthCare Medical Group Specialists. Dmand AI also links Manju John to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Manju John practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Manju John's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Manju John is licensed in Connecticut.

CMS data shows 2,102 Medicare services from Manju John across 17 procedure codes in 2024, for 1,008 Medicare patients. Medicare paid $119,510 for them.

CMS counts 1,008 Medicare patients who saw Manju John in 2024. The largest group is 75 to 84, with 383 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Manju John's median patient age at 68, with 56% women.

In 2024, Manju John wrote 6,108 Medicare Part D claims for 878 patients. 83% of them were for generic drugs. CMS names the drug for 5,878 of them, across 46 drugs with 11 or more claims each, at $1,108,832 in total drug cost. In 2023, CMS named 4,340 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Manju John for performance year 2024, reported as part of a group. Manju John accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 88 general payments to Manju John from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Bristol-Myers Squibb Company paid the most, $256.